DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Crescendo Biologics
Crescendo Biologics
Crescendo Biologics is focused on novel T cell enhancingtherapeutics in immuno-oncology.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 0
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 3
Financing history
0 rounds
No dated round yet.
Investors on record
4 edges
- Andera Partners portfolio listing Fact crescendobiologics.com
- Sofinnova Partners portfolio listing Fact crescendobiologics.com
- Future Planet Capital Limited portfolio listing Fact futureplanetcapital.com
- Sofinnova Partners portfolio listing Fact sofinnovapartners.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
0
No dated event.
Evidence
8 observations
Every observation on this company
- Description: Crescendo Biologics is focused on novel T cell enhancingtherapeutics in immuno-oncology. Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)
- Investors named on site: 2 Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)
- Listed on portfolio page: Future Planet Capital Limited Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Sofinnova Partners Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Future Planet Capital Limited Sep 14, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Sofinnova Partners Sep 12, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Website status: ok Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)
- Site title: Crescendo Biologics - The T cell enhancing company Sep 17, 2026 Fact Portfolio company websites (about, investors, press pages)